Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized‐controlled study on the effects of loop‐ and thiazide‐diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women

作者: L. Rejnmark , P. Vestergaard , L. Heickendorff , F. Andreasen , L. Mosekilde

DOI: 10.1046/J.1365-2362.2001.00883.X

关键词:

摘要: Background Thiazide diuretics (TD) reduce urinary calcium, bone loss and fracture risk. Loop (LD) may have opposite effects. These effects could depend on induced rhythmic changes in calcium homeostasis. Design After a run-in period of 7 days, we studied (in factorial design) the diurnal rhythms plasma levels phosphate, parathyroid hormone (PTH), 1,25-dihydroxyvitamin D osteocalcin, as well renal excretions rates cross-linked N-terminal telopeptide type 1 collagen (NTx) 50 postmenopausal women randomized to treatment with either thiazide diuretic (TD; bendroflumethiazide, n = 14), loop (LD; bumetanide, n = 13), LD plus TD (bendroflumethiazide n = 11), or placebo (n = 12). Results In all four groups, measured quantities showed variation. caused steep increase, subsequent decrease, PTH. The mean 24 h PTH concentration was increased (8·5 ± 0·9 mmol L−1) compared (4·4 ± 0·4 mmol L−1), whereas net excretion did not differ from that group due rebound hypocalciuria. Compared placebo, phosphate osteocalcin were changed an increase during daytime decrease night. alter rhythm any quantities. However, 24-h decreased, without suppression. similar those observed alone. Conclusion One daily dose increases activity alterations pattern osteocalcin. This indicate potential anabolic effect LD.

参考文章(39)
Ib Transbøl, Ib Homum, Steffen Hahnemann, Eivin Hasner, Henrik Øhlenschlaeger, Henrik Diemer, Knud Lockwood, Tubular reabsorption of calcium in the differential diagnosis of hypercalcaemia. Further experience. Acta Medica Scandinavica. ,vol. 188, pp. 505- 522 ,(2009) , 10.1111/J.0954-6820.1970.TB08076.X
C Rosenquist, P Qvist, N Bjarnason, C Christiansen, Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies Clinical Chemistry. ,vol. 41, pp. 1439- 1445 ,(1995) , 10.1093/CLINCHEM/41.10.1439
Brandon J Orr-Walker, Judith M Clearwater, Anne M Horne, Margaret C Evans, M.A.F Murray, Alan R McNeil, Greg D Gamble, Ian R Reid, Ruth W Ames, Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial The American Journal of Medicine. ,vol. 109, pp. 362- 370 ,(2000) , 10.1016/S0002-9343(00)00510-6
Toshiro Fujita, James C.M. Chan, Frederic C. Bartter †, Effects of oral furosemide and salt loading on parathyroid function in normal subjects. Physiological basis for renal hypercalciuria. Nephron. ,vol. 38, pp. 109- 114 ,(1984) , 10.1159/000183290
PATRICIA A. GABOW, Furosemide-Induced Reduction in Ionized Calcium in Hypoparathyroid Patients Annals of Internal Medicine. ,vol. 86, pp. 579- 581 ,(1977) , 10.7326/0003-4819-86-5-579
A Blumsohn, K Herrington, R A Hannon, P Shao, D R Eyre, R Eastell, The effect of calcium supplementation on the circadian rhythm of bone resorption. The Journal of Clinical Endocrinology and Metabolism. ,vol. 79, pp. 730- 735 ,(1994) , 10.1210/JCEM.79.3.8077353
Horacio Plotkin, Caren Gundberg, Maryann Mitnick, Andrew F. Stewart, Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis. The Journal of Clinical Endocrinology and Metabolism. ,vol. 83, pp. 2786- 2791 ,(1998) , 10.1210/JCEM.83.8.5047
F. Schønau Jørgensen, S. Brünner, The Long-Term Effect of Bendroflumethjazide on Renal Calcium and Magnesium Excretion and Stone Formatjon in Patients with Recurring Renal Stones Scandinavian Journal of Urology and Nephrology. ,vol. 8, pp. 128- 131 ,(1974) , 10.3109/00365597409132117
S Rashiq, R F Logan, Role of drugs in fractures of the femoral neck. BMJ. ,vol. 292, pp. 861- 863 ,(1986) , 10.1136/BMJ.292.6524.861